GILD- Gilead Sciences, Inc.

Across the last three months, Gilead Sciences, Inc.'s insiders have reduced their positions by a net 15,000 shares worth roughly $2.0M.

GILD sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	O'Day Daniel Patrick	92.1K	$12.74M	-
Other	Wilfong Diane E.	46.6K	$6.45M	-
Other	Mercier Johanna	27.9K	$3.85M	-
CFO	Dickinson Andrew D	27.9K	$3.85M	-
VP	Cain Wettan Keeley M	20.0K	$2.77M	-

Buys and sells only

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Apr 27, 2020	Cogan John Francis	Director	Sale+OE	2,413	$79.90	$192,798.70	-4.2%
Apr 20, 2020	Cogan John Francis	Director	Sale+OE	2,413	$83.00	$200,279.00	-4.2%
Apr 13, 2020	Cogan John Francis	Director	Sale+OE	2,413	$75.90	$183,146.70	-4.2%
Apr 6, 2020	Cogan John Francis	Director	Sale+OE	2,413	$79.52	$191,881.76	-4.2%
Mar 30, 2020	Cogan John Francis	Director	Sale+OE	2,413	$75.35	$181,819.55	-4.2%
Mar 23, 2020	Cogan John Francis	Director	Sale+OE	2,413	$75.27	$181,626.51	-4.2%
Mar 16, 2020	Cogan John Francis	Director	Sale+OE	2,413	$67.26	$162,298.38	-4.2%
Mar 10, 2020	Pletcher Brett A	EVP,Corp Affairs &Gen Counsel	Sale+OE	2,950	$75.55	$222,872.50	-16.8%
Mar 9, 2020	Cogan John Francis	Director	Sale+OE	2,413	$77.97	$188,141.61	-4.2%
Mar 2, 2020	Pletcher Brett A	EVP,Corp Affairs &Gen Counsel	Sell	10,441	$70.88	$740,013.53	-25.6%